A 4814 New Jersey General Assembly · 2024-2025 Regular Session

Establishes tianeptine as Schedule II controlled dangerous substance.

This bill classifies tianeptine, an antidepressant medication, as a Schedule II controlled substance under New Jersey law. It makes possession, distribution, or manufacturing of tianeptine illegal without authorization, with penalties including up to 10 years in prison for larger quantities (second-degree crime) or 3-5 years for smaller amounts (third-degree crime). The law directly affects anyone possessing or distributing tianeptine, including patients prescribed the drug, as it would require a prescription to legally obtain it. The policy change aligns tianeptine with other high-risk substances under New Jersey’s Controlled Dangerous Substances Act.
Bill status signed all 5 stages cleared
Introduction
Sep 2024
Committee Review
Feb 2025
General Assembly Passage
Feb 2025
Senate Passage
Dec 2025
Signed into Law
Jan 2026
Introduced Sep 19, 2024 Signed Jan 12, 2026
Floor votes · Senate Dec 18, 2025 · General Assembly Feb 27, 2025

How they voted

380
Passed · 2 other
Total votes 40
Dec 18, 2025
D Democratic25
24 Yea 1
96% Yea
R Republican15
14 Yea 1
93% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
7
Key actions
4
Committee
1
Jan 12, 2026
Signed into law
Approved P.L.2025, c.249.
executive
Dec 18, 2025
Upper · Passed
Passed Senate (Passed Both Houses) (38-0)
upper
Feb 27, 2025
Lower · Passed
Passed Assembly (75-0-0)
lower
Feb 13, 2025
Lower · Passed
Reported out of Assembly Committee, 2nd Reading
lower
Sep 19, 2024
Introduced
Introduced in the Assembly, Referred to Assembly Judiciary Committee
lower
3 primary · 3 co-sponsors

Sponsors